We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Drugs Less Effective Than Lifestyle Modifications in Increasing HDL

By Biotechdaily staff writers
Posted on 05 Sep 2007
A recently published review article suggested that lifestyle modifications were more successful in raising high-density lipoprotein (HDL) levels than most available drug treatments.

Nearly 40% of all heart attacks and related cardiovascular problems occur in individuals with low HDL levels. More...
Those with blood levels of HDL lower than 35 mg/dl (16-18% of men and 3- 6% of women) have eight times the risk of heart disease compared to those with 65 mg/dl or more. Thus, finding drug treatments to raise the level of HDL has become of major interest.

A team of investigators reviewed the literature related to attempts to raise HDL levels and compared results from lifestyle modification (dieting, exercise, etc.) to those from various drug treatments. Results of the review of 31 randomized controlled trials published in the August 15, 2007, issue of the Journal of the American Medical Association revealed that several lifestyle modifications were effective in increasing HDL. Among these lifestyle modifications were weight loss, exercise, smoking cessation, moderate alcohol consumption, and eating fish or taking fish oil to increase intake of omega-3 fatty acids.

As for pharmacologic approaches, the study found that the most effective currently available drug to raise HDL is the vitamin niacin, taken in high doses. "Statins, niacin, and fibrates are available pharmacological agents that increase HDL; however, they may be associated with adverse side effects,” said contributing author Dr. Mehdi Shishehbor from the Cleveland Clinic (OH, USA).

"Despite the recent negative HDL trials, this field is extremely exciting and the pace of discovery is unbelievably fast,” Dr. Shishehbor said. "At least one other drug with a novel mechanism of action is also in trials--and at least three other approaches have led to new drugs in the pipeline.”


Related Links:
Cleveland Clinic

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Microbiology

view channel
Image: Overview of a rapid diagnostic workflow for fungal bloodstream infections (Photo courtesy of Professor Hiroki Takahashi and IMO, Chiba University, Japan)

Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.